DISEASE INDICATIONS: Psoriasis
MANUFACTURER: Boehringer Ingelheim
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Spevigo (spesolimab-sbzo) is a prescription medication used to treat generalized pustular psoriasis (GPP) flares in adults. GPP is a rare autoinflammatory skin disease that can cause painful pustules (blisters) to form all over the body. Spevigo is the first FDA-approved treatment for GPP flares.
